Baxter International Inc. (NYSE:BAX) Shares Acquired by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. lifted its stake in Baxter International Inc. (NYSE:BAX - Free Report) by 1.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,160,666 shares of the medical instruments supplier's stock after acquiring an additional 21,592 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 0.23% of Baxter International worth $33,845,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. ARGA Investment Management LP boosted its stake in Baxter International by 148.8% during the fourth quarter. ARGA Investment Management LP now owns 870,601 shares of the medical instruments supplier's stock worth $25,387,000 after buying an additional 520,633 shares in the last quarter. Forsta AP Fonden boosted its stake in shares of Baxter International by 140.5% in the 4th quarter. Forsta AP Fonden now owns 273,900 shares of the medical instruments supplier's stock valued at $7,987,000 after purchasing an additional 160,000 shares in the last quarter. CKW Financial Group boosted its stake in shares of Baxter International by 19.3% in the 4th quarter. CKW Financial Group now owns 2,625 shares of the medical instruments supplier's stock valued at $77,000 after purchasing an additional 425 shares in the last quarter. SG Americas Securities LLC boosted its stake in shares of Baxter International by 99.8% in the 4th quarter. SG Americas Securities LLC now owns 16,371 shares of the medical instruments supplier's stock valued at $477,000 after purchasing an additional 8,179 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its stake in shares of Baxter International by 10.2% in the 4th quarter. Nisa Investment Advisors LLC now owns 97,990 shares of the medical instruments supplier's stock valued at $2,874,000 after purchasing an additional 9,054 shares in the last quarter. Institutional investors and hedge funds own 90.19% of the company's stock.

Baxter International Stock Up 0.7 %

Baxter International stock traded up $0.21 during trading on Friday, hitting $30.83. 3,855,412 shares of the company were exchanged, compared to its average volume of 4,554,846. The business's 50 day moving average is $30.55 and its 200 day moving average is $34.26. Baxter International Inc. has a 52 week low of $28.33 and a 52 week high of $44.01. The company has a market capitalization of $15.74 billion, a P/E ratio of 154.16, a PEG ratio of 9.83 and a beta of 0.61. The company has a current ratio of 1.43, a quick ratio of 1.09 and a debt-to-equity ratio of 1.31.

Baxter International Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Friday, February 28th will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Friday, February 28th. This represents a $0.68 dividend on an annualized basis and a yield of 2.21%. Baxter International's dividend payout ratio (DPR) is 340.02%.

Wall Street Analysts Forecast Growth

BAX has been the topic of several recent analyst reports. Stifel Nicolaus reduced their target price on shares of Baxter International from $46.00 to $38.00 and set a "buy" rating on the stock in a research note on Monday, November 11th. Citigroup lowered their price target on Baxter International from $37.00 to $35.00 and set a "neutral" rating for the company in a research note on Wednesday, December 11th. Finally, StockNews.com downgraded Baxter International from a "buy" rating to a "hold" rating in a research report on Monday, November 11th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $39.44.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.